Company / Scientific Committee /

STENTYS has selected some of the world’s most prominent cardiologists to be part of its Scientific Advisory Board to support its scientific research. These cardiologists have done tremendous scientific and clinical work in interventional cardiology and their advice is highly valued by STENTYS:

A NEW ERA IN THE TREATMENT OF CORONARY DISEASE

The STENTYS self-apposing stent is a fundamental innovation that radically improves the treatment of myocardial infarction and represents a breakthrough in the way it is treated.  As we better understand the devastating consequences of malapposition, the STENTYS approach, while resolving artery mismatch with conventional stents, represents a new era in the treatment of coronary disease and improves the outcome of this deadly disease. 

Adressing a $ 2 billion market, STENTYS is on the path to control this key market. 

Michel Darnaud, Chairman

 
Updated 2017-05-31